Modeling Supports Determination of First-In-Human (FIH) Dosing and Rapid Titration to Final Dose for Subcutaneous Administration of LIPO-102 Ken Locke, PhD1, Jim Bosley, PhD2*, Steven Kern, PhD2, Toufigh Gordi, PhD2, Ron

First Page		Document Content
Date: 2014-01-18 12:32:05		Modeling Supports Determination of First-In-Human (FIH) Dosing and Rapid Titration to Final Dose for Subcutaneous Administration of LIPO-102 Ken Locke, PhD1, Jim Bosley, PhD2*, Steven Kern, PhD2, Toufigh Gordi, PhD2, Ron Add to Reading List Source URL: www.rosaandco.com Download Document from Source Website File Size: 659,53 KB Share Document on Facebook